Ritedose to invest up to $110M in South Carolina plant

A South Carolina drug manufacturer is planning a significant plant expansion that could double its capacity and add more than 5 dozen jobs in the next 5 years.  

Ritedose, which has been operating in Columbia, SC, for 20 years, plans to invest up to $110 million in its plant there, the South Carolina Department of Commerce says. The drugmaker will add about 80,000 square feet to the 120,000-square-foot facility and said that if it gets FDA approval for its new operations and for new products, it will add up to 65 jobs in the next 5 years.

The Ritedose plant, which specializes in inhalation products as well as eye and ear drops, can currently produce about 1 billion units a year. With the expansion, it expects its capacity to reach 2 billion units.

North Carolina, with its concentration of companies around Raleigh, usually announces plant projects for the region. Purdue Pharma is building a new $59 million plant in Durham, NC. The 188,000-square-foot facility is expected to open next year with 100 employees. Merck ($MRK) got a large upgrade of a vaccine manufacturing plant in Durham approved last year by the FDA, part of a $1 billion upgrade to its vaccine operations.

- here's the release